Martha M. Rumore, PharmD, JD, MS, LLM, FAPhA is Of Counsel at Health Law Alliance and a registered U.S. Patent Attorney

Frequently Asked Questions

The U.S. Department of Justice is actively pursuing an investigation into alleged Medicare fraud involving the unauthorized use of senior citizens' ID numbers across several states to order COVID-19 tests that were neither requested nor needed.

According to a healthcare fraud prosecutor within the Justice Department, who has chosen to remain anonymous due to the ongoing nature of the investigation, there have been instances where rapid tests were billed under the names of deceased individuals. This investigation is still in its early stages, and federal authorities are only beginning to understand the full extent of the alleged fraud, which involves hundreds of thousands of tests and affects seniors and their families in at least 10 states.

A Closer Look at the Context and Challenges Faced by Providers

It is important to recognize that these allegations arise in the context of the federal government’s response to a significant public health emergency. In an effort to address the nationwide shortage of COVID-19 tests during the 2021 holiday season, the Biden administration moved quickly to expand access to free tests in early 2022. Unfortunately, the rapid deployment of this initiative may have led to unintended consequences, including the potential for misuse by third parties.

While there are claims of widespread fraud, it is crucial to approach these allegations with caution. Providers who participated in the government's efforts to distribute tests were operating under extraordinary circumstances and were responding to an urgent need to make testing available to vulnerable populations. The alleged actions of a few bad actors should not overshadow the broader context in which these providers were working.

Moreover, it is worth noting that the Centers for Medicare & Medicaid Services (CMS) has received only a small number of complaints relative to the total number of Medicare beneficiaries. The majority of providers acted in good faith and within the bounds of the law.

Advocating for Fair Investigations: Defending Providers Amid Pandemic-Related Fraud Allegations

As legal counsel for providers, we will continue to advocate for a fair and balanced investigation that considers the unprecedented challenges faced during the pandemic. It is essential that the government’s response to these allegations does not unjustly penalize those who were genuinely trying to help during a time of crisis. We remain committed to defending our clients against any unwarranted claims and ensuring that justice is served.

MORE ARTICLES BY CATEGORY

Get a Free Consultation

100% Confidential & Secure. Your details are safe with us.

We'll speak soon!

In the meantime, why not find out more about us or visit our blog.

Alternatively, give us a call at (800) 345 - 4125

Oops! Something went wrong while submitting the form.

Why PBMs are Investigating Provider-Patient Relationships—And What it Means for Your Pharmacy

PBMs are ramping up audit pressure in 2026, now targeting provider-patient relationships to justify recoupments and even network terminations. Without precise documentation, even well-established prescriptions can put pharmacies at serious financial and operational risk.

Read More >>

HLA Wins Full Reversal of PBM Credentialing Denial for an Independent Pharmacy

This week, Health Law Alliance achieved full reversal of a PBM credentialing denial for a New York pharmacy—mere weeks after it received a termination notice. Read more to learn how Health Law Alliance’s tireless advocacy can help your pharmacy in credentialing disputes.

Read More >>

From Prior Authorization to Network Termination: The PBM Audit Trend Independent Pharmacies Must Watch

PBMs are increasingly targeting pharmacies over their role in the prior authorization process, using vague allegations to justify massive recoupments and even terminations. Without airtight documentation and clear procedures, even compliant pharmacies can face serious financial and legal risk.

Read More >>

The 2025 Healthcare Fraud Takedown Is a Warning Shot for Wound Care Providers

Wound care is now an enforcement priority. The 2025 fraud takedown targets skin substitute billing, graft utilization, and Medicare compliance.

Read More >>